MedPath

Safety and Clinical Outcomes of Percutaneous Cryoablation for Musculoskeletal Tumor: a Phase-II Clinical Study

Phase 2
Conditions
musculoskeletal tumor
Registration Number
JPRN-UMIN000009906
Lead Sponsor
Department of Radiology, Mie University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria is an abnormal coagulability as defined by platelet count of less than 50,000/mm3, and an international normalized ratio (INR) of greater than 1.5.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath